OKYO Pharma

OKYO Pharma is a clinical stage biopharmaceutical company focused on developing therapies for inflammatory dry eye disease and neuropathic corneal pain. Their drug candidate, OK-101, is designed to target a key ocular receptor to control inflammation and ocular pain.

OK-101 Drug Candidate
Therapies for Dry Eye Disease
Therapies for Neuropathic Corneal Pain

Size

Small

Phone

N/A

Website

okyopharma.com

N/A

Locations

55 Park Ln, W1K 1NA

02074952379

Digital Popularity

Social Media

LinkedIn
771 Followers

Competitors

AstraZeneca

AstraZeneca is a research-based bio-pharmaceutical company that focuses on the discovery, development, and commercialisation of innovative medicines.

William Harvey Research Limited

William Harvey Research Limited is a contract research organisation established in 1990, specialising in preclinical drug evaluation services for the Biotech and Pharmaceutical sectors.

Viramal

Viramal is a specialist pharmaceutical company based in the UK and Sweden, focused on developing transformative biological and vaginal well-being products for women.

Celadon Pharmaceuticals

Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines.

Company Details

OKYO Pharma is operated by Okyo Pharma Limited and is a Active company incorporated on 1 April 2018 with the registered office located in . Okyo Pharma Limited was registered 7 years ago.

Status

Active

Size

Micro

Directors

Age

7 years old

Employees

Unreported

Turnover

Unreported

Total Assets